The No Surprises Act (NSA) was signed into law as part of the Consolidated Appropriations Act of 2021 (CAA). It includes transparency provisions that require group health plans to report information on prescription drugs and healthcare spending to the Departments of Labor and Health and Human Services and the Treasury. This reporting process, known as prescription drug data collection, or RxDC, report, is due by June 1 each year.
Download the bulletin to get detailed insights into these requirements and learn more about what steps employers should take.
